Securities code: 002589 securities abbreviation: Realcan Pharmaceutical Group Co.Ltd(002589) Announcement No.: 2022-011 Realcan Pharmaceutical Group Co.Ltd(002589)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements and major omissions.
1、 Important tips
There was no increase, rejection or change of proposals during the convening of the general meeting of shareholders. This general meeting of shareholders does not involve the change of the resolution of the previous general meeting of shareholders.
2、 Notice of meeting
The Realcan Pharmaceutical Group Co.Ltd(002589) notice on convening the first extraordinary general meeting of shareholders in 2022 was disclosed in the securities times, China Securities News, Securities Daily, Shanghai Securities News and cninfo.com on January 24, 2022.
3、 Basic information of the meeting
1. Convener: Board of directors
The 18th meeting of the 4th board of directors held on January 21, 2022 deliberated and approved the proposal on convening the first extraordinary general meeting of shareholders in 2022, and agreed to convene this general meeting. 2. Meeting time: 15:00 PM, Wednesday, February 9, 2022
3. Meeting place: conference room on the fourth floor of the company, No. 326, Jichang Road, Yantai City, Shandong Province
4. Moderator: Mr. Han Xu, chairman
5. Meeting mode: on site meeting combined with online voting
6. The convening and convening of this meeting comply with the provisions of the company law, the rules for the general meeting of shareholders of listed companies, the Listing Rules of Shenzhen Stock Exchange, the articles of association and other relevant laws, regulations and normative documents.
4、 Attendance at the meeting
A total of 21 shareholders and their proxies participated in the voting, representing 193912236 shares, accounting for 12.8870% of the total voting shares of the company. Of which:
1. There were 2 Shareholders and their proxies attending the on-site meeting, representing 188507807 shares, accounting for 12.5278% of the total voting shares of the company;
2. A total of 19 shareholders participated in online voting, with 5404429 representative shares, accounting for 0.3592% of the total voting shares of the company;
There were 20 minority shareholders in this meeting, representing 6420339 shares, accounting for 0.4267% of the total voting shares of the company.
3. Some directors, supervisors and senior managers of the company attended the meeting as nonvoting delegates, and lawyers of Shandong Qianyuan law firm attended the shareholders’ meeting to witness.
5、 Voting at the meeting
The shareholders’ meeting considered the following proposals by combining on-site voting and online voting, and the voting results are as follows:
The proposal on renewing the appointment of accounting firms was deliberated and adopted.
Voting: 193646636 shares were approved, 203600 shares were opposed and 62000 shares were abstained, accounting for 99.8630%, 0.1050% and 0.0320% of the voting shares attending the meeting respectively.
Among them, the total voting of minority shareholders: 6154739 shares in favor, 203600 shares against and 62000 shares abstained, accounting for 95.8631%, 3.1712% and 0.9657% of the shares held by minority shareholders attending the meeting respectively.
6、 Lawyer witness
The meeting was witnessed by Shandong Qianyuan law firm and issued the legal opinion. According to the legal opinion, the convening and convening procedures of this general meeting of shareholders, the qualifications of the participants and conveners and the deliberation and voting procedures of the meeting are in line with the provisions of laws and regulations, normative documents and the articles of association, and the voting results of the meeting are legal and effective.
7、 Documents for future reference
1. Resolution of the first extraordinary general meeting of shareholders in Realcan Pharmaceutical Group Co.Ltd(002589) 2022
2. Legal opinion of Shandong Qianyuan law firm on Realcan Pharmaceutical Group Co.Ltd(002589) the first extraordinary general meeting of shareholders in 2022
It is hereby announced.
Realcan Pharmaceutical Group Co.Ltd(002589) February 10, 2022
